Association of the novel aminoglycoside resistance determinant RmtF with NDM carbapenemase in Enterobacteriaceae isolated in India and the UK
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Association of the novel aminoglycoside resistance determinant RmtF with NDM carbapenemase in Enterobacteriaceae isolated in India and the UK
Authors
Keywords
-
Journal
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume 68, Issue 7, Pages 1543-1550
Publisher
Oxford University Press (OUP)
Online
2013-04-12
DOI
10.1093/jac/dkt078
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- RmtF, a New Member of the Aminoglycoside Resistance 16S rRNA N7 G1405 Methyltransferase Family
- (2012) Marc Galimand et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Fitness Cost and Interference of Arm/Rmt Aminoglycoside Resistance with the RsmF Housekeeping Methyltransferases
- (2012) Belen Gutierrez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Association of Extended-Spectrum β-Lactamase VEB-5 and 16S rRNA Methyltransferase ArmA in Salmonella enterica from the United Kingdom
- (2012) Laura Hidalgo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Scabies in the developing world–-its prevalence, complications, and management
- (2012) R.J. Hay et al. CLINICAL MICROBIOLOGY AND INFECTION
- Exogenously acquired 16S rRNA methyltransferases found in aminoglycoside-resistant pathogenic Gram-negative bacteria: An update
- (2012) Jun-ichi Wachino et al. DRUG RESISTANCE UPDATES
- F33:A−:B− and F2:A−:B− Plasmids Mediate Dissemination ofrmtB-blaCTX-M-9Group Genes andrmtB-qepAin Enterobacteriaceae Isolates from Pets in China
- (2011) Yuting Deng et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- ArmA Methyltransferase in a Monophasic Salmonella enterica Isolate from Food
- (2011) Sophie A. Granier et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline
- (2011) David M. Livermore et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Breakthrough bacteraemia due to tigecycline-resistant Escherichia coli with New Delhi metallo- -lactamase (NDM)-1 successfully treated with colistin in a patient with calciphylaxis
- (2011) N. R. H. Stone et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Multilocus sequence typing of IncN plasmids
- (2011) Aurora García-Fernández et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Complete Sequencing of pNDM-HK Encoding NDM-1 Carbapenemase from a Multidrug-Resistant Escherichia coli Strain Isolated in Hong Kong
- (2011) Pak Leung Ho et al. PLoS One
- Structures of the Bacterial Ribosome in Classical and Hybrid States of tRNA Binding
- (2011) J. A. Dunkle et al. SCIENCE
- Discovery of a Gene Conferring Multiple-Aminoglycoside Resistance in Escherichia coli
- (2010) M. A. Davis et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Complete Nucleotide Sequence of Klebsiella pneumoniae Multidrug Resistance Plasmid pKP048, Carrying blaKPC-2, blaDHA-1, qnrB4, and armA
- (2010) Y. Jiang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Coexistence of blaOXA-23 with blaNDM-1 and armA in clinical isolates of Acinetobacter baumannii from India
- (2010) K. Karthikeyan et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study
- (2010) Karthikeyan K Kumarasamy et al. LANCET INFECTIOUS DISEASES
- Characterization of a New Metallo- -Lactamase Gene, blaNDM-1, and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India
- (2009) D. Yong et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started